Third Arc Bio Revenue and Competitors

Location

$198M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Third Arc Bio's estimated annual revenue is currently $5.1M per year.(i)
  • Third Arc Bio's estimated revenue per employee is $155,000
  • Third Arc Bio's total funding is $198M.

Employee Data

  • Third Arc Bio has 33 Employees.(i)
  • Third Arc Bio grew their employee count by 154% last year.

Third Arc Bio's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Scientific Officer and FounderReveal Email/Phone
3
COOReveal Email/Phone
4
VP, Oncology ResearchReveal Email/Phone
5
SVP, CMCReveal Email/Phone
6
Senior Associate DirectorReveal Email/Phone
7
Senior Director Strategy and OperationsReveal Email/Phone
8
Director, Clinical OperationsReveal Email/Phone
9
Senior Director Project ManagementReveal Email/Phone
10
Manager, R&DReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.4M9-10%N/AN/A
#2
$7.1M4677%N/AN/A
#3
$14.4M9327%N/AN/A
#4
$0.9M60%N/AN/A
#5
$1.6M1043%N/AN/A
#6
$11.5M746%N/AN/A
#7
$0.9M1122%N/AN/A
#8
$3.7M24-8%N/AN/A
#9
$2M1318%N/AN/A
#10
$9.3M602%N/AN/A
Add Company

What Is Third Arc Bio?

Third Arc Bio is a biotech company developing multifunctional antibodies that generate immune synapses that precisely activate or inhibit T cells. The company’s drug development engine delivers superior biologics optimized to create best-in-class T cell engagement by leveraging two technologies that power a pipeline of high value therapeutics – a solid tumor synergy platform and an I&I platform that offers a novel approach to precision immune regulation at a tissue-specific level to achieve superior efficacy and safety. To learn more, visit www.thirdarcbio.com.

keywords:N/A

$198M

Total Funding

33

Number of Employees

$5.1M

Revenue (est)

154%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.8M3310%$5M
#2
$4.6M3343%N/A
#3
$6M3310%N/A
#4
$3.8M33-6%N/A
#5
$6.5M330%N/A